Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase II study of FIL ONLUS.

ABSTRACT:

SUBMITTER: Stefoni V 

PROVIDER: S-EPMC7556670 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature